Early data show generally positive outcomes following bilateral implantation of a new extended depth of focus (EDOF) intraocular lens.
A retrospective analysis of clinical and patient reported outcomes three month after bilateral implantation of the Zeiss AT Lara 829MP (Carl Zeiss Meditec AG) in 293 patients found that 86.7 percent of eyes were within 0.50 diopters of emmetropia.
Most patients, 95.4 percent, were spectacle-free for distance vision and 83.6 percent were spectacle-free for near vision.
“This is the first cohort of patients who have had this lens implanted at Optical Express” said Julie M. Schallhorn, MD, MS, assistant professor of ophthalmology at the University of California, San Francisco. “Especially in our younger patients, in their 50s and 60s, so much of our lives are on our phones and tablets. Having a lens that can give you that phone vision and tablet vision without sacrificing distance vision, is very, very attractive for patients.”
RELATED CONTENT: How to manage patient’s IOL expectations pre-operatively
JULIE M. SCHALLHORN, MD, MS
This article is based on Dr. Schallhorn’s presentation at the 2019 American Society of Cataract and Refractive Surgery annual meeting. Dr. Schallhorn has no financial disclosures to report.